(Q33479686)

English

4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

phase II clinical trial

0 references

author name string

Schütte J

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Niederle N

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Grunenberg B

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Krischke W

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Seeber S

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Schmidt CG

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

38-41

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Relationship between the effect on calcium turnover and early cardiotoxicity of doxorubicin and 4'-epi-doxorubicin in guinea pig heart muscle

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary phase I study of 4'-epi-adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase of I trial of 4'-epi-Adriamycin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental evaluation of anthracycline analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of aclacinomycin A in acute leukemia and various solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4'-epi-doxorubicin in metastatic renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/6583205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00395488

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33479686&oldid=2195399435"